Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Milyavsky

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Scientific Reports|March 28, 2025
Novel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemiaDipak Walunj, Katarina Egarmina, Adi Zipin-Roitman, et al.
International Journal of Cancer|November 5, 2016
Quercetin alters the DNA damage response in human hematopoietic stem and progenitor cells via TopoII- and PI3K-dependent mechanisms synergizing in leukemogenic rearrangementsShahar Biechonski, Dana Gourevich, Melanie Rall, et al.
Biochemical Pharmacology|July 21, 2019
The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulatorsKatia Beider, Hanna Bitner, Valeria Voevoda-Dimenshtein, et al.
Cell Stem Cell|July 13, 2010
A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewalMichael Milyavsky, Olga I Gan, Magan Trottier, et al.
Cancer Research|June 9, 2019
An <i>ERG</i> Enhancer-Based Reporter Identifies Leukemia Cells with Elevated Leukemogenic Potential Driven by ERG-USP9X Feed-Forward RegulationNasma Aqaqe, Muhammad Yassin, Abed Alkader Yassin, et al.
Nature Communications|April 29, 2021
Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joiningTzah Feldman, Akhiad Bercovich, Yoni Moskovitz, et al.
Plos One|March 20, 2010
A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotypeYosef Buganim, Ido Goldstein, Doron Lipson, et al.
Leukemia|February 2, 2019
A novel method for detecting the cellular stemness state in normal and leukemic human hematopoietic cells can predict disease outcome and drug sensitivityMuhammad Yassin, Nasma Aqaqe, Abed Alkader Yassin, et al.
Scientific Reports|April 19, 2018
Attenuated DNA damage responses and increased apoptosis characterize human hematopoietic stem cells exposed to irradiationShahar Biechonski, Leonid Olender, Adi Zipin-Roitman, et al.
Cancer Cell|February 13, 2007
Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defectMichael Milyavsky, Igor Shats, Alina Cholostoy, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Scientific Reports|March 28, 2025
Novel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemiaDipak Walunj, Katarina Egarmina, Adi Zipin-Roitman, et al.
International Journal of Cancer|November 5, 2016
Quercetin alters the DNA damage response in human hematopoietic stem and progenitor cells via TopoII- and PI3K-dependent mechanisms synergizing in leukemogenic rearrangementsShahar Biechonski, Dana Gourevich, Melanie Rall, et al.
Biochemical Pharmacology|July 21, 2019
The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulatorsKatia Beider, Hanna Bitner, Valeria Voevoda-Dimenshtein, et al.
Cell Stem Cell|July 13, 2010
A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewalMichael Milyavsky, Olga I Gan, Magan Trottier, et al.
Cancer Research|June 9, 2019
An <i>ERG</i> Enhancer-Based Reporter Identifies Leukemia Cells with Elevated Leukemogenic Potential Driven by ERG-USP9X Feed-Forward RegulationNasma Aqaqe, Muhammad Yassin, Abed Alkader Yassin, et al.
Nature Communications|April 29, 2021
Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joiningTzah Feldman, Akhiad Bercovich, Yoni Moskovitz, et al.
Plos One|March 20, 2010
A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotypeYosef Buganim, Ido Goldstein, Doron Lipson, et al.
Leukemia|February 2, 2019
A novel method for detecting the cellular stemness state in normal and leukemic human hematopoietic cells can predict disease outcome and drug sensitivityMuhammad Yassin, Nasma Aqaqe, Abed Alkader Yassin, et al.
Scientific Reports|April 19, 2018
Attenuated DNA damage responses and increased apoptosis characterize human hematopoietic stem cells exposed to irradiationShahar Biechonski, Leonid Olender, Adi Zipin-Roitman, et al.
Cancer Cell|February 13, 2007
Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defectMichael Milyavsky, Igor Shats, Alina Cholostoy, et al.
Pageof 5